Autoimmune Diseases

Latest News

FDA Approves IV Formulation of Cosentyx
FDA Approves IV Formulation of Cosentyx

October 9th 2023

The IV formulation, a monthly 30-minute, weight-based dosing option, has a wholesale acquisition cost of $2,115 per vial. It will be available in the fourth quarter.

  Psychological — Not Just Physical — Symptoms Hamper Physical Fitness in Patients with RA
Psychological — Not Just Physical — Symptoms Hamper Physical Fitness in Patients with RA

August 9th 2023

RA Associated with Increased Risk of Heart Attack, Stroke, Finds Meta-Analysis
RA Associated with Increased Risk of Heart Attack, Stroke, Finds Meta-Analysis

July 12th 2023

CAR T Cells Could Change the Face of Autoimmune Therapy |  Research Review
CAR T Cells Could Change the Face of Autoimmune Therapy | Research Review

June 28th 2023

Analyses Confirm Link Between Thyroid Autoimmunity and Hearing Risks
Analyses Confirm Link Between Thyroid Autoimmunity and Hearing Risks

June 21st 2023

More News

© 2024 MJH Life Sciences

All rights reserved.